← FDA Drug Approvals (Drugs@FDA)

EFAVIRENZ

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2015-11-23

Drug application

FDA Application #

ANDA091175

Application type

Abbreviated New Drug Application (Generic)

Brand name

EFAVIRENZ

Generic name

Efavirenz

Active ingredients

EFAVIRENZ

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

TEVA PHARMS USA

First approval

2015-11-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown